These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 9067471)
41. Apolipoprotein E modulates Alzheimer's Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner. Lauderback CM; Kanski J; Hackett JM; Maeda N; Kindy MS; Butterfield DA Brain Res; 2002 Jan; 924(1):90-7. PubMed ID: 11743999 [TBL] [Abstract][Full Text] [Related]
42. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner. Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918 [TBL] [Abstract][Full Text] [Related]
43. APOE ε4 is associated with higher levels of CSF SNAP-25 in prodromal Alzheimer's disease. Wang S; Zhang J; Pan T; Neurosci Lett; 2018 Oct; 685():109-113. PubMed ID: 30144541 [TBL] [Abstract][Full Text] [Related]
44. Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease. Drigalenko E; Poduslo S; Elston R Neurology; 1998 Jul; 51(1):131-5. PubMed ID: 9674791 [TBL] [Abstract][Full Text] [Related]
45. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Myers RH; Schaefer EJ; Wilson PW; D'Agostino R; Ordovas JM; Espino A; Au R; White RF; Knoefel JE; Cobb JL; McNulty KA; Beiser A; Wolf PA Neurology; 1996 Mar; 46(3):673-7. PubMed ID: 8618665 [TBL] [Abstract][Full Text] [Related]
47. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease. Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669 [TBL] [Abstract][Full Text] [Related]
48. Two types of sporadic cerebral amyloid angiopathy. Thal DR; Ghebremedhin E; Rüb U; Yamaguchi H; Del Tredici K; Braak H J Neuropathol Exp Neurol; 2002 Mar; 61(3):282-93. PubMed ID: 11895043 [TBL] [Abstract][Full Text] [Related]
49. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele. Pahnke J; Walker LC; Schroeder E; Vogelgesang S; Stausske D; Walther R; Warzok RW Acta Neuropathol; 2003 Jan; 105(1):25-9. PubMed ID: 12471457 [TBL] [Abstract][Full Text] [Related]
50. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112 [TBL] [Abstract][Full Text] [Related]
51. Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the epsilon4 allele on regional cerebral blood flow. Høgh P; Knudsen GM; Kjaer KH; Jørgensen OS; Paulson OB; Waldemar G J Geriatr Psychiatry Neurol; 2001; 14(1):42-51. PubMed ID: 11281316 [TBL] [Abstract][Full Text] [Related]
53. Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Reiman EM; Chen K; Alexander GE; Caselli RJ; Bandy D; Osborne D; Saunders AM; Hardy J Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8299-302. PubMed ID: 15932949 [TBL] [Abstract][Full Text] [Related]
54. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Lue LF; Kuo YM; Roher AE; Brachova L; Shen Y; Sue L; Beach T; Kurth JH; Rydel RE; Rogers J Am J Pathol; 1999 Sep; 155(3):853-62. PubMed ID: 10487842 [TBL] [Abstract][Full Text] [Related]
55. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum. Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT; Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664 [TBL] [Abstract][Full Text] [Related]
56. Apolipoprotein E4 and beta amyloid in senile plaques and cerebral blood vessels of aged rhesus monkeys. Poduri A; Gearing M; Rebeck GW; Mirra SS; Tigges J; Hyman BT Am J Pathol; 1994 Jun; 144(6):1183-7. PubMed ID: 8203459 [TBL] [Abstract][Full Text] [Related]
57. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Strittmatter WJ; Weisgraber KH; Huang DY; Dong LM; Salvesen GS; Pericak-Vance M; Schmechel D; Saunders AM; Goldgaber D; Roses AD Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8098-102. PubMed ID: 8367470 [TBL] [Abstract][Full Text] [Related]
58. The Neurobiology and Age-Related Prevalence of the ε4 Allele of Apolipoprotein E in Alzheimer's Disease Cohorts. Heffernan AL; Chidgey C; Peng P; Masters CL; Roberts BR J Mol Neurosci; 2016 Nov; 60(3):316-324. PubMed ID: 27498201 [TBL] [Abstract][Full Text] [Related]
59. Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease. Monastero R; Mariani E; Camarda C; Ingegni T; Averna MR; Senin U; Camarda R; Mecocci P Acta Psychiatr Scand; 2006 Jan; 113(1):59-63. PubMed ID: 16390371 [TBL] [Abstract][Full Text] [Related]
60. Apolipoprotein E alleles and brain vascular pathology in Alzheimer's disease. Kalaria RN; Cohen DL; Premkumar DR Ann N Y Acad Sci; 1996 Jan; 777():266-70. PubMed ID: 8624096 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]